Table 1 Primers used in this study.
From: Optimization of capsid-incorporated antigens for a novel adenovirus vaccine approach
| 33RGD -(as) | CGGGATCCTGCTTCGGCCTCAGCGCGC |
| 33RGD -(s) | CGGGATCCGCCGCGGCAATGCAGCC |
| 43RGD -(as) | CGGGATCCGGCAGCTTCGGCCGCTG |
| 43RGD -(a) | CGGGATCCAACTCCAACGCGGCAGCC |
| 53RGD -(as) | CGGGATCCTTGCGCAGCGGGGGC |
| 53RGD -(a) | CGGGATCCAGCGGCGCGGAAGAGAACTC |
| 63RGD -(as) | CGGGATCCCTTCTCGACCTCGGGTTGCG |
| 63RGD -(a) | CGGGATCCAGCAACAGCAGTGGCAGCG |
| 73RGD -(as) | CGGGATCCCGGTTTCTTCTGAGGCTTCTCG |
| 73RGD -(a) | CGGGATCCGGTGGCGCAGGCGG |
| 83RGD -(as) | CGGGATCCCAGGGGTTTGATCACCGGTTT |
| 83RGD -(a) | CGGGATCCACCGAACAGGGCGGGG |
| 3'HVR5-(as) | GGCATGTAAGAAATATGAGTGTCTGGG |
| 5'HVR2-(s) | CTCACGTATTTGGGCAGGCGCC |